The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 41, Issue 7, Pages 101042831882481
Publisher
SAGE Publications
Online
2019-07-12
DOI
10.1177/1010428318824815
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
- (2016) Guido Sauter et al. EUROPEAN UROLOGY
- The role of GATA2 in lethal prostate cancer aggressiveness
- (2016) Veronica Rodriguez-Bravo et al. Nature Reviews Urology
- FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
- (2016) J C Zhao et al. ONCOGENE
- p16 upregulation is linked to poor prognosis in ERG negative prostate cancer
- (2016) Christoph Burdelski et al. TUMOR BIOLOGY
- Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner
- (2016) Kevin J Tam et al. Oncotarget
- The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- (2015) Christoph Burdelski et al. BMC CANCER
- Haematopoietic and immune defects associated withGATA2mutation
- (2015) Matthew Collin et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- GATA2 as a potential metastasis-driving gene in prostate cancer
- (2015) Yan Ting Chiang et al. Oncotarget
- The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
- (2014) Katharina Grupp et al. INTERNATIONAL JOURNAL OF CANCER
- Androgens and androgen receptor signaling in prostate tumorigenesis
- (2014) Ye Zhou et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
- (2014) Bin He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Prostate Cancer — Uncertainty and a Way Forward
- (2012) Ian M. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
- (2012) E. H. Bresnick et al. NUCLEIC ACIDS RESEARCH
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Pioneer transcription factors: establishing competence for gene expression
- (2011) K. S. Zaret et al. GENES & DEVELOPMENT
- ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
- (2011) S. Taoudi et al. GENES & DEVELOPMENT
- Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading
- (2011) Lars Egevad et al. VIRCHOWS ARCHIV
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
- (2010) S. Minner et al. CLINICAL CANCER RESEARCH
- Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer
- (2009) C. Cai et al. CANCER RESEARCH
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes
- (2009) M Böhm et al. ONCOGENE
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now